+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Plantar Fasciitis Treatment Market - Growth, Trends, and Forecasts (2020 - 2025)

  • ID: 5176863
  • Report
  • August 2020
  • Region: Global
  • 111 pages
  • Mordor Intelligence
1 of 5

FEATURED COMPANIES

  • Algeo Limited
  • Bauerfeind
  • GlaxoSmithKline plc
  • Hanger Clinic.
  • Ottobock
  • Pfizer, Inc
  • MORE
The Plantar Fasciitis Treatment Market is expected to register a CAGR of nearly 6.8% during the forecast period. Increasing adoption of orthotics technique coupled with increasing number of plantar fasciitis cases are the major factors driving the growth of the market globally.

According to the National Center for Health Statistics (NCHS) report, it is estimated that about two million population suffers from plantar fasciitis every year globally. Moreover, growing obese population is also attributing for the growth of the market studied as obese people are at greater risk of developing plantar fasciitis.

Furthermore, increasing geriatric population, growing technological advancements, availability of various treatment options are also few factors fueling the growth of plantar fasciitis treatment market. However, high cost of the treatment and lack of awareness about the plantar fasciitis condition are hindering the growth of plantar fasciitis treatment market.

Key Market Trends

Orthotic Devices Segment is Expected to Dominate the Global Plantar Fasciitis Treatment Market Over the Forecast Period

Orthotic devices are also called orthoses, are the type of braces helps in supporting the weakened muscles while running and walking. They also improve comfort and helps in slowing the progress of contractures (tightened muscles or tendons that become shorter over time).
  • Orthotic devices can be worn at any time of the day or night. The use of a specific orthotic device depends on the patient’s type of concern. The main types of orthotic devices include ankle-foot orthoses and knee-ankle-foot orthoses.
  • Plantar fasciitis typically occurs as a result of flattening of the foot. This flattening of the arch makes the foot appear larger, one of the best ways to ease the burden on the foot is by essentially replacing the structure of the arch. Orthotics can be a valuable solution for people struggling with the discomfort of plantar fasciitis.
  • According to a Health and Wellness Survey report by Richard L Nahin et al., published in Journal of Pain 2018, estimated the prevalence of plantar fasciitis in United States adults which was highest among women (1.19%) compared to men (0.47%), in population aged 45 to 64 (1.33%) versus population aged 18 to 44 (0.53%).
  • Hence, to reach the consumer requirements market players are focussing on developing various novel and technological advanced Orthotic devices which is anticipated to propel the overall market.
North America is Expected to Dominate the Global Plantar Fasciitis Treatment Market Over the Forecast Period

North America holds a significant market share in the global plantar fasciitis treatment market and is expected to withstand its position over the forecast period. The diagnosis and prevalence rates of plantar fasciitis are growing rapidly in the region. Additionally, the rise in the number of obese people in the U.S. and changing lifestyle is also driving the plantar fasciitis treatment market in North America.
  • As per National Clinical Trials (NCT) registry, as of June 18, 2020, currently, there are about 6 recruiting clinical trials across different phases of development for the treatment of Plantar Fasciitis in the United States.
  • Owing to the growing healthcare expenditure, high investments in the development of new products, large population base with foot pain conditions, and expansion in the distribution networks of leading players are the major factors driving the market in the Asia Pacific region.
Competitive Landscape

The Plantar Fasciitis Treatment Market is consolidated competitive. Currently, many private companies are focusing on the development and introduction of novel products into the market which is easily affordable and accessible. Some of the key innovations in the market include in 2017, BioElectronics Corporation received USFDA approval of ActiPatch as drugfree pain therapy for plantar fasciitis and osteoarthritis.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Algeo Limited
  • Bauerfeind
  • GlaxoSmithKline plc
  • Hanger Clinic.
  • Ottobock
  • Pfizer, Inc
  • MORE
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Availability of Technically Advanced Products And Solutions For Treatment of Plantar Fasciitis
4.2.2 Growing Cases of Plantar Fasciitis Couple With Increasing Obesity
4.3 Market Restraints
4.3.1 High Cost of the Treatment
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Treatment Type
5.1.1 Pharmacological Treatment
5.1.2 Orthotic devices
5.1.3 Shockwave Therapy
5.1.4 Surgery
5.1.5 Other Treatment Types
5.2 End-User
5.2.1 Hospitals
5.2.2 Orthopedic Clinics
5.2.3 Other End-Users
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Shapecrunch Technology Pvt Ltd
6.1.2 Ottobock
6.1.3 Algeo Limited
6.1.4 Bauerfeind
6.1.5 Scholl's Wellness Co.
6.1.6 SUPERFEET WORLDWIDE, INC.
6.1.7 GlaxoSmithKline plc
6.1.8 Sanofi
6.1.9 Pfizer, Inc
6.1.10 Hanger Clinic.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Shapecrunch Technology Pvt Ltd
  • Ottobock
  • Algeo Limited
  • Bauerfeind
  • Scholl's Wellness Co.
  • SUPERFEET WORLDWIDE, INC.
  • GlaxoSmithKline plc
  • Sanofi
  • Pfizer, Inc
  • Hanger Clinic.
Note: Product cover images may vary from those shown
5 of 5

Loading
LOADING...

Adroll
adroll